Objective: The unfavorable costs and effects of currently accessible antidepressant agents necessitate the development of more potent and safe alternatives, that will obviate the potential problems associated with the commercially available marketed ones.
Md. Rafat Tahsin +9 more
doaj +1 more source
Optimal treatment of social phobia: systematic review and meta-analysis
John Canton, Kate M Scott, Paul GlueDepartment of Psychological Medicine, Dunedin School of Medicine, University of Otago, Dunedin, New ZealandAbstract: This article proposes a number of recommendations for the treatment of generalized social phobia ...
Scott KM, Canton J, Glue P
doaj
The MAO-B Inhibitor Selegiline Reduces the Viability of Different Prostate Cancer Cell Lines and Enhances the Effects of Anti-Androgen and Cytostatic Agents. [PDF]
Steib A +8 more
europepmc +1 more source
Preventing relapse in patients with major depressive disorder after an effective acute course of electroconvulsive therapy. [PDF]
Song M +5 more
europepmc +1 more source
On the Origins of MAOI Misconceptions: Reaffirming their Role in Melancholic Depression. [PDF]
Van den Eynde V +6 more
europepmc +1 more source
Serotonin Availability Shapes the Effects of Phenelzine on Inflammatory Response and Gene Expression in Macrophages. [PDF]
Mahdianipur S +5 more
europepmc +1 more source
Medicines for Anxiety: A Hundred Years of Tranquillity and More to Come? [PDF]
Nutt D.
europepmc +1 more source
Structural Principles of Covalent Flavin Modification in Oxidoreductases. [PDF]
Tanner JJ.
europepmc +1 more source
Selegiline, a monoamine oxidase-B inhibitor as a modulator of metabolic reprogramming for cancer therapy: a review. [PDF]
Jayachandran J +6 more
europepmc +1 more source
Antidepressants and Lung Toxicity: A Narrative Review. [PDF]
Shooshtari AA +5 more
europepmc +1 more source

